The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporte ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.

We list the limitations and new findings from these pieces ... new research also recently found a link between chronic obstructive pulmonary disease (COPD) symptoms and GLP-1 medications. The study ...

The study, involving nearly 394,000 adults, demonstrates that certain diabetes medications may offer unexpected benefits for respiratory health. Global health projections indicate that COPD will ...

Marijuana has been removed from the banned substances list in WWE's Wellness Policy. This was revealed by Michin during a recent appearance on The Speakeezy podcast, who opened up about various ...